Related Experiment Video
Updated: Jun 16, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Protein C and Protein S: causative factor for developing a hemorrhagic infarct in a HbE/Beta thalassemia child
Sharma Vineeta1, Arijit Biswas, Bijender Kumar
1Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
Insights
This study identifies Protein C and Protein S deficiency as the cause of hemorrhagic infarct in a child with HbE/Beta thalassemia. This finding highlights a crucial link between specific genetic mutations and coagulation disorders.
Area of Science:
- Hematology
- Neurology
- Genetics
Background:
- HbE/Beta thalassemia is a common hemoglobinopathy.
- Hemorrhagic infarcts are rare in pediatric patients, especially those with hemoglobinopathies.
- Understanding the etiology of infarcts in this population is critical for effective management.
Observation:
- A 10-year-old child with HbE/Beta thalassemia presented with occipitotemporal hemorrhagic infarct and frontal white matter gliotic changes.
- Genetic testing revealed HbE and IVS1-5 mutations, but no thrombogenic mutations.
- Magnetic resonance imaging confirmed the hemorrhagic infarct.
Findings:
- Low antigenic levels of Protein C and Protein S were detected in the patient.
- Protein C and Protein S deficiency were identified as the causative factors for the hemorrhagic infarct.
- The absence of thrombogenic mutations suggests a non-thrombotic pathway for infarct development.
Implications:
- This case underscores the importance of evaluating coagulation factors in pediatric patients with HbE/Beta thalassemia presenting with infarcts.
- Early diagnosis and management of Protein C and Protein S deficiency can prevent recurrent thromboembolic events.
- Further research is warranted to explore the interplay between hemoglobinopathies and inherited thrombophilias.
Abstract:
A 10-yr-old HbE/Beta thalassemia child who developed subacute to chronic occipitotemporal hemorrhagic infarct with smaller chronic infarct with gliotic changes in the left frontal periventricular white matter. Genetic tests showed that patient was positive for HbE and IVS1-5 mutation and was negative for thrombogenic mutations. Hemorrhagic infarct was confirmed by magnetic resonance imaging study. Antigenic levels of Protein C and Protein S were low. Based on these outcomes, it was concluded that Protein C and Protein S deficiency were the causative factor for developing hemorrhagic infarct in the HbE/Beta thalassemia patient.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemorrhagic Stroke l: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
